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Abstract 
 Technology transfer is the process by which universities and other higher education 
institutions (HEIs) channel discovered knowledge and innovations into commercialization. 
Increasing commercialization has been a feature of HEIs in the United States, especially, for the 
last several decades. A turning point can be seen with the passage of what is known as the Bayh-
Dole Act in 1980. This landmark piece of legislation allowed universities to keep licensing rights 
from federally funded projects, an institutional ownership model that spurred innovation. HEIs 
with medical schools are especially affected due to the lucrative nature of biotechnology. 
 One such measure of innovation and, crucially, commercialization is the number of 
patents filed per institution. As such, patent data has been obtained for a sample of HEIs in New 
York State, Ireland, and New Zealand. For benchmarking activity levels, data has also been 
compiled on the volume of journal publications from each school. Using the statistical software 
Minitab to analyze these data sets, this paper finds (1) evidence of a significant acceleration in 
patenting activity after Bayh-Dole, and (2) that increased patenting rates may be causing 
deceleration in publishing activities at HEIs with medical schools.  
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Executive Summary 
 
 This study works with patent and publishing data from the last 40 years to understand and 
comment on trends in the commercialization of Higher Education Institutions (HEIs). HEI is a 
broader catchall term for university-level education and research organizations. These last few 
decades have seen the advent of the entrepreneurial university: going beyond the tradition two 
missions (education, research) to a third mission of commercialization. 
 It is now commonplace for HEIs, Syracuse University included, to have a Technology 
Transfer Office (TTO) on campus. TTOs are responsible for helping bring to market innovations 
developed or researched on campus. Therefore, TTOs become the middleman between HEIs, 
industry, and government in how new knowledge and innovations are disseminated. Such 
operations include a wide range of possible activities, including patenting, licensing, facilitating 
entrepreneurial spinout ventures, or otherwise seeking to generate revenue. 
 In New York State, the average founding year for TTOs is 1985. This likely accounts for 
a lag after what many consider to be the catalyst for the entrepreneurial university, passage in 
1980 of the Bayh-Dole Act. This legislation amended United States patent law to reflect an 
institutional ownership model whereby HEIs almost completely control the licensing of 
innovations resulting from federally funded research. With few exceptions, the HEI controls how 
an innovation is brought to market. Previously, the federal government could mandate that only 
non-exclusive licenses were granted. Thusly, before Bayh-Dole, if a company invested in 
licensing and making an innovation market-ready, there would not be an intellectual property 
protection to stop other market participants from imitating. 
 These changes to patent law unleashed a wave of innovation and commercialization at 
HEIs, but especially those with medical schools. This is because biotechnology is a field where 
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innovations can be extremely lucrative. Academics are thus encouraged to commercialize 
innovation (Siegel and Wessner 2012). Pharmaceutical and medical device inventions discovered 
at HEIs can generate revenue in the hundreds of millions – not often, but it does happen. Within 
the patent and publishing data accumulated for this study, a distinction was made between 
schools with and without a medical school for these reasons. 
 This study’s methodology is built on the framework of a comparative and longitudinal 
analysis across geographies and types of HEIs. Patenting and publishing data from HEIs in New 
York State, Ireland, and New Zealand were assembled for the years 1973-2007. These countries 
provided large data sets with a mix of public and private HEIs, with and without medical 
schools, in mature technology transfer environments. Arranged longitudinally, the data was then 
reduced per country by the number of HEIs in each category. For instance, with 18 HEIs in New 
York State and 12 of them operating medical schools, total New York figures were divided by 
18, HEIs with medical school figures were divided by 12, and HEIs without medical school 
figures were divided by six. 
 The resulting graphs visualized what had been expected behavior in the wake of Bayh-
Dole. An acceleration in patenting occurs after 1980, first in the United States and then in the 
other two countries as the institutional ownership model was replicated. Publishing data grew in 
a comparatively linear fashion over the same time period. Interestingly, the produced graphs 
appear to show a deceleration in publishing as patenting continues to increase in HEIs with 
medical schools. This trend is present in the data for all three countries surveyed. 
 This significance of such a phenomenon would be conflict between the second and third 
missions of HEIs: research and commercialization of knowledge. While patenting is only one 
measure of commercialization, this is an area that deserves further study. 
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Advice to Future Honors Students 
 
“Don’t panic.” 
 
–Douglas Adams, The Hitchhiker’s Guide to the Galaxy
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Introduction 
 
 
 
 
In recent years, universities have grown to play an outsized role in national innovation systems. 
As centers of knowledge creation, in the form of academic research, it makes sense that 
universities should become highly integrated within a national economy – particularly in a 
globalized world where information and innovation travel across geographies instantaneously. 
This study will examine the changing nature of universities within innovation systems, as well as 
how parties such as government and industry have affected and been affected by these changes. 
 Particularly of interest is the instrumentality of Bayh-Dole, a piece of legislation from 
1980, in creating this environment in the United States, and then serving as a model for other 
countries. In general terms, patents (and the resulting potential of licensing) can be used as a 
proxy measurement of overall commercialization, and that is what this analysis seeks to confirm 
using 1980 as a global turning point. 
 
What is an innovation system? What is the Triple Helix? 
 
 Innovation systems are the interactions between and within institutions that coordinate to 
include knowledge production in a national economy. Recent studies have noted the 
transformation of many universities, especially in the United States, to include an entrepreneurial 
bent, a “third mission,” alongside traditional goals of teaching and research (Breznitz and 
Feldman, 2012; Breznitz et al., 2008). An effective visualization of the way these changes have 
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affected larger innovation systems is by use of the triple helix: essentially a Venn diagram 
showing the overlap between institutions in higher education, industry, and government 
(Etzkowitz and Leydesdorff, 1999).  
What role do HEIs and TTOs play in innovation systems? 
 
 Higher education institutions in a traditional “two-mission” approach primarily contribute 
two things to innovation systems: educated students and research. The entrepreneurial 
university’s third mission is expeditiously commercializing these outputs by bringing them to 
market in more controlled ways. Thusly, the entrepreneurial university is an acknowledgement of 
“[reduced] distance among institutional spheres” in a knowledge-driven economy (Etzkowitz et 
al, 2000). To promote economic success, governments, industry, and HEIs are working more 
closely – and that means the latter group actively pushing its innovation. 
 The establishment of technology transfer offices (TTOs) within universities has 
facilitated this change. These offices are explicitly tasked full-time with bringing professors’ 
research to market. Common measures of productivity for the entrepreneurial university are 
number of patents obtained and number of licensing agreements. There are, of course, other 
measures of success that bring more nuance to the impact of an institution’s accomplishment; 
some examples are the number of licensees, start-ups formed, and their survival, or the size of 
revenue streams from resulting technologies. 
 Through this process, the ultimate goal is increasing the efficiency of an HEIs ability to 
bring knowledge to market. The TTO becomes the liaison, or middleman, between academics 
and industry agents, allowing professors to continue their research with minimal distraction and 
TTOs to specialize in finding the right industry partner for a patent or invention. 
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 Outside of TTOs, another example of university activities being commercialized can be 
seen in a changing student experience, one more aligned with industry. Commercialization 
happens in the integration of students into the workforce before graduation (internships or co-
ops) or collaboration between HEI and industry institutions to provide immersive professional 
experiences. The entrepreneurial university model affects more than just professors and 
university coffers – the student experience is undoubtedly affected and the type of research 
conducted is necessarily skewed toward IP that can lead to potentially profitable business 
ventures. 
 Above all, a successful TTO is the interface of the Triple Helix. It is the outward-facing 
agent of a university, but its chief quality is somewhat membranous. TTOs facilitate the chief 
goals (knowledge production, knowledge commercialization, economic growth) of three sectors 
(HEIs, industry, government, respectively) while not being directly involved in the execution of 
any. TTOs are not discovering the new knowledge, directly bringing it to consumers, or using it 
in order to stimulate regional growth. 
 
How can we understand the internal dynamics of the Triple Helix? 
 
 Etzkowitz et al identify four key processes for understanding change in the “production, 
exchange, and use of knowledge” (2000) in the dynamic of a Triple Helix. The first process is 
internal change led and executed within a helix – an example being HEIs choosing to adopt the 
“third mission.” This is a point that we perhaps take for granted today – that universities would 
naturally pursue commercially relevant activities related to economically viable topics. The 
second process is change driven by inter-helix influence, such as the impact of Bayh-Dole 
legislation on incentivizing the commercialization of HEI research. In that case, the overlay is 
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influence being exercised by one helix (government) over another (HEIs) in defined 
relationships. Informal relationships can also exercise influence, as “the cutting edge” might 
necessarily reflect the nature of related research being done and the way graduates are prepared. 
The third process is the creation and development of institutions that overlay more than one 
helix: i.e. any public-private partnership arrangement overlays industry and government, while 
affecting change in both spheres. Finally, the fourth process driving change in the Triple Helix is 
referred to as being “recursive” – engendering the aggregated effects of the networks created by 
the first three processes over time. 
 The university has thusly been raised to the level of industry in the practical sense of 
pursuing the economic rewards resulting from knowledge creation; HEIs have always done the 
latter, but the former is much newer territory. There are some surface-level problems with this 
new arrangement that should be apparent with minimal reflection. People learn on the job just as 
they do in classrooms – especially in highly technical and professional roles that require new 
knowledge be processed. If companies can teach and universities can act like businesses, the 
difference between the helices is altogether blurred. When one competes with another in the 
same arenas, perhaps universities should legally be treated like other market participants. Amid 
these changes, the role of government has also changed in some instances with the rise of public-
private partnerships to spur economic growth and investment. It is unclear where such an 
arrangement would fall into the Triple Helix model. Fully-entrepreneurial universities and 
public-private ventures are just two examples of why the neat, discrete boxes of the Triple Helix 
framework are somewhat limiting. 
 To understand fully how these various dynamic came to be requires a detailed look at the 
passage of The Patent and Trademark Law Amendments Act of 1980, better known as Bayh-
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Dole, and how the spheres of the Triple Helix interacted beforehand. It is notable that the Act is 
what its sponsor, Senator Birch Bayh (D-IN), might be best known for considering that his other 
accomplishments include writing two amendments of the U.S. Constitution, Title IX of the 
Higher Education Act, and serving nearly two decades in the Senate. 
 
The Bayh-Dole Act of 1980 background 
 As stated previously, Bayh-Dole incentivized commercialization of federally funded 
university research. In 1980 the U.S. economy contracted by 0.3 percent, down from GDP 
growth of 5.6 percent two years previous. Partly as a response to a sluggish economy, but also in 
reaction to the economic potential of universities going unrealized, U.S. patent law was 
drastically changed. Previously, the status quo held that the U.S. government could assert 
ownership over whatever resulted from federal funding dollars and require that licensing was 
done on a non-exclusive basis. Such an IP ownership model discourages first movers from 
investing in university-created technologies – should that first mover see any success, the lack of 
a non-exclusive license would provide competing firms with all the benefits and none of the 
risks. As such, “…a Chinese wall [was] erected between academic and corporate research. 
Research was literally described as being “contaminated” by federal funding because of the 
government’s licensing policies (Loise & Stevens, 2010).” 
 The scale of this problem was truly stunning: before Bayh-Dole, the U.S. government 
owned 28,000 patents from university research but only 4 percent had found their way to the 
private sector in the form of licenses (Ibid). These innovations were treated as toxic because of 
the hyper-competitive nature of non-exclusive ownership. Bayh-Dole’s simple solution was to 
almost entirely revoke the federal government’s rights to the research it paid for: instead, the 
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institutions conducting the research now had sole ownership. Small provisions were included in 
the law’s text for such secondary issues as the right of inventors to a portion of resulting income, 
a preference for licensing to small businesses, and the necessity of manufacturing domestically 
consumed goods in the U.S. – but institutional ownership was still revolutionary. 
 
Practical impacts of legislation 
 
 This is best demonstrated by the explosion of innovation soon after passage of Bayh-
Dole, as the private sector could then acquire exclusive patent licenses for potentially valuable 
technologies. The number of U.S. institutions with offices serving technology transfer purposes 
went from around 20 before Bayh-Dole to over 200 today – this simple law essentially began the 
entrepreneurial university model used worldwide today. Some of the many innovations that have 
since arisen from this process are the internet web browser, nicotine patches, cochlear implants, 
and mobile phones (AUTM). As one might imagine, these kinds of inventions are rare but quite 
lucrative. In 2008, U.S. universities saw licensing revenues of $3.4 billion, making the same 
figure in 1981, $7.3 million, look quite paltry (Loise & Stevens, 2010). 
 Health-related technologies and their related industries have been the biggest 
beneficiaries of this revolution. In 1995, just 15 years after Bayh-Dole, 54 percent of federal 
dollars for university research and development came from the Department of Health and Human 
Services. That figure, which amounted to more than $6.5 billion, came almost entirely from the 
National Institutes of Health (GAO, 1995). As is common with medical innovations, exceptional 
moneymakers are few and far between but exceptionally lucrative. Of the $3.4 billion in 
licensing revenues universities earned in 2008, 24 percent of that figure was royalties paid to 
Northwestern University by Pfizer for the license to Lyrica, a drug used to treat epileptic seizures 
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and other neuropathic conditions (Loise & Stevens, 2010). Indeed, five licensing institutions, 
four of which were hospitals or medical schools, accounted for a full 53 percent of total 
university licensing revenue in 2008 – the remaining 47 percent went to the other 180 reporting 
institutions (Ibid). This suggests two things: that financially successful technology transfer 
operations are primarily medical, and that the majority of institutions do not see the vast riches of 
commercial success. 
 The level of inequality is stark between the top and bottom earners, and this fact shows in 
the proportion of technology transfer operations that are unprofitable for their hosting academic 
institution. According to Loise & Stevens (2010), in 2006 only 16 percent of U.S. institutions 
with technology transfer activities actually covered their operating costs with income from 
licensing and other commercial activity. Partly, this is because the benefits of these innovations 
are experienced in the private sector or by researchers themselves. But the overall sense remains 
that, despite Bayh-Dole and the potential it unlocked, most schools cannot and do not depend on 
income from commercialization. 
 Roessner et al (2013) suggest that there is a prima facie case to be made for the Bayh-
Dole Act having spurred the significant economic growth seen as a result of university research 
after passage in 1980. The creation and growth of a multibillion industry, biotechnology, is 
credited to the increasing contributions of universities to innovation made possible by Bayh-Dole 
(BIO, 2009). The ingrained nature of academic research in this field is illuminated by the fact 
that 76 percent of biotechnology companies hold a university license and, further, 50 percent of 
such companies actually began from university licenses (Ibid). Far from being limited to 
boutique labs and small start ups, in 2008, these firms accounted for 1.42 million jobs in the 
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United States alone (Ibid). The economic impact is wide reaching, from institutions, to regions, 
and across industrial sectors. 
 
Criticisms of Bayh-Dole 
 In 2005, The Economist labeled the Bayh-Dole Act as “a law of unintended 
consequences.” Among its criticisms, The Economist decries the “Third Mission” of HEIs in 
everything but name, saying, “…[Bayh-Dole] makes American academic institutions behave 
more like businesses than neutral arbiters of truth.” Further, they charge that the pace of research 
and technological advancement, along with the collaborative spirit of academia, is negatively 
impacted due to concerns of secrecy or eventual royalties. Particular cases from Columbia 
University and the University of Utah are cited, where a legal attempt was made to reclaim an 
expired patent and an essential technology was exclusively licensed to one firm, respectively. 
Such actions seem antithetical to academic notions of strictly pursuing knowledge. 
 Philosophically, practically, and certainly legally, the question of academia’s function is 
thusly muddled. A 2002 Federal Circuit court ruling essentially dismantled the “experimental use 
defense” for universities accused of infringing on a current patent (Cai, 2004). Michelle Cai, of 
University of California – Berkeley, noted that this “shattered a long-held myth that universities 
are immune.” The case’s logic is that universities should not be exempt from charges of 
infringement precisely because of the overtly commercial nature of processes such as technology 
transfer. Universities are competing, with each other and sometimes with industry groups, for 
research dollars and any resulting revenue streams. In regards to a professor and a company both 
infringing a patent for research purposes: why should a court of law distinguish between these 
commercial activities and give a clear advantage to one group? This extraordinary ruling can be 
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seen as the result of an academic-entrepreneurial culture catalyzed by the Bayh-Dole Act 22 
years previous. 
 The situation of researchers commercializing their work “may be problematic and lead to 
real or perceived conflict of interest unless the nature of overlap, co-mingling and ties are clearly 
elucidated” (Murray, 2002). That “overlap” between the academic and commercial worlds 
inherently bestows perceived bias, especially in the cases of particularly lucrative subjects such 
as discoveries in biotechnology. There is a distinction to be made here, of course, between 
simply the “transfer of tacit knowledge” versus “active participation” – the latter being certainly 
more problematic (Murray, 2002). 
 
Data set – patents by HEI, country 
 
 In order to better understand technology transfer – domestically and in an international 
context – I will be examining data from three countries: the United States, Ireland, and New 
Zealand. While the United States can be thought of as the birthplace of technology transfer 
because of first-mover advantage and wide variety of participating institutions, Ireland and New 
Zealand both have fairly sophisticated and mature HEI commercialization operations as well. As 
the amount of data relating to schools in the United States, their patents and publications, is 
predictably large and unwieldy, it makes sense to focus simply on research institutions in New 
York State. 
 New York State’s 18 schools with technology transfer operations serve as an interesting 
microcosm of commercialization across different types of institutions: it is a healthy mix of 
public and private institutions, as well as medical and non-medical schools. The latter detail is 
relevant for the aforementioned reason of biotechnology’s prominent roots in university research. 
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Medical university research seems more likely to have lucrative innovations, and thus be a richer 
source of patents than non-medical studies (Chapple et al., 2005; Jensen et al., 2003; Thursby et 
al., 2001). Further, in academia there is sometimes the dilemma of whether to patent or publish: 
situations where publishing cutting-edge information could threaten eventual claim to an 
exclusive patent (Daizadeh et al. 2002). Of the six New York State institutions without medical 
schools, two are primarily focused on technology (Rochester Institute of Technology, Rensselaer 
Polytechnic Institute), two are private research universities (Syracuse University, Clarkson 
University), and two are public institutions (Binghamton University, University at Albany). 
 Ireland and New Zealand provide geographical diversity, as well as the different context 
of exclusively public universities. Of the eight major New Zealand research institutions with 
technology transfer operations, only two have medical schools and both were relative latecomers 
to commercialization with founding of TTO offices in 1998 and 2002 for the University of 
Auckland and University of Otago, respectively. The opposite is true in Ireland: five of the seven 
major research institutions have medical schools and two do not. One of the Irish institutions 
with a medical school, National University of Ireland, Galway, stands out for having formed a 
technology transfer office in 1973, nearly a decade before the explosion in the U.S. prompted by 
Bayh-Dole. For New Zealand, Ireland, and New York State, the average founding year for their 
technology transfer office was 1996, 1991, and 1985, respectively. The New York State figure is 
likely indicative of several years’ lag time after passage of Bayh-Dole.  
 Information on patents granted per university is available publically online from the 
appropriate governmental office of each country. For the three countries in this study, those 
offices are the U.S. Patent and Trademark Office, the Irish Patents Office, and the Intellectual 
Property Office of New Zealand. It should be noted that the mere amount of patenting at an HEI 
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is not the ultimate measure of “commercialization” in the most general sense, but reliable data 
for a better indicator is not easily available. The degree to which an institution is truly 
commercialized must necessarily rely upon diverse data sets such as a breakdown of funding 
sources, revenue earned, all patent and licensing measures, the number of spinoff companies and 
their success in terms of revenue and employees, and other activities typical of the 
entrepreneurial university’s designation as such. 
 But even within patents, not all are created equally. Northwestern University’s patent for 
the drug Lyrica, generating annual revenue in the hundreds of millions of dollars, should not 
count as equal to a never licensed, never cited patent in some obscure niche of engineering. 
Though the former is more rare, both such examples are equally sized data points in terms of this 
data set. This is because patents are likely still the best proxy available, and we use caution in 
interpreting this data as not to misrepresent that fact. 
 
Data set – publications by HEI, country 
 If the first area of study in this paper is a longitudinal analysis of patenting, its second 
focus is the relationship between patents and publishing of academic journal articles. As 
discussed briefly above, certain fields of academic sometimes struggle with the question of 
whether to patent or publish a new idea. A hypothesis, therefore, is that the data should bear out 
this relationship that the amount of patenting negatively affects publishing rates. 
 Publishing data was acquired from Web of Science, Thomson Reuters’ subscription-
based proprietary index for academic journal publications. Similarly to the patent data, it is worth 
noting that not all papers are created equal. Some articles become highly influential in their 
fields, garnering hundreds of citations and becoming the cornerstone of subsequent influential 
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works. Other papers go largely unnoticed, unread, and un-cited. In both of these cases, this data 
set weighs such papers as equal. The qualitative determination of relative value and merit in 
academic publications is not the question at hand and it is sufficient, for the purposes of this 
study, that a team of editors vetted each article. 
 
Methodology 
 Reliable patenting and publishing data from 1973 to 2007 and, importantly, this range 
includes the passage of Bayh-Dole in 1980. Pre-1973 publication data from Web of Science 
appeared to be incomplete, and was thusly excluded. Post-2007 patenting data from the relevant 
governmental bodies was also unreliable, as the proper tracking and recording of patents is an 
arduous process requiring years. That is how the range of years, 1973-2007, was arrived at – the 
seemingly most reliable data for both patenting and publishing that included 1980. 
 The data, separated into categories by HEI and country, were assembled in Minitab 
statistical software for ease of analysis. Within each country’s categorization, a distinction was 
also made between schools that do and do not have medical schools. With totals by year for 
publishing and patenting, the data was then divided by the number of schools in a category to 
arrive at a “per capita” average for universities with medical schools (“Med”), universities 
without (“Non-Med”), and total country figures. 
 For instance, New York State’s schools had 38,053 publications and 238 patents filed in 
2007. Of these, 34,438 publications and 216 patents came from Med schools. The data therefore 
seems quite lopsided against Non-Med institutions, but less so when you consider that there are 
twice as many Med schools (12 of 18 in NYS). In this case, for New York in 2007, the “per 
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capita” average when divided by the number of schools was 2869.83 Med publications vs. 602.5 
Non-Med publications, and 18.0 Med patents vs. 3.667 Non-Med patents. 
 
Findings 
 
 
Fig. 1: Comparison of patents per HEI in NYS, Ireland, NZ 
 
 
 
Fig. 2: Comparison of publications per HEI in NYS, Ireland, NZ in the years 1973-2007 
 
 
 In the case of both patents and publications, the volume of activity per university has 
increased tremendously since the 1970’s. An acceleration of activity is more obvious in the case 
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of patents in Fig. 1, where the New York HEIs are near even with those in Ireland and New 
Zealand before 1980. Starting around that time, the per-university figure for patents increases 
tremendously before exploding in the 1990’s. This may be due to a lag in assembling technology 
transfer processes at individual institutions – hiring and training staff as well as establishing 
relationships with the professors doing research. In Fig. 2, for publishing, growth is steadier and 
appears to be approximately linear in all three countries. This can likely be accounted for by the 
increasing size of universities globally, a much likelier conclusion than a constant number of 
professors becoming 3-5X more productive. 
 
Fig. 3: Fitted line plot of New York State schools’ patents vs. publications 
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Fig. 4: Fitted line plot of Irish schools’ patents vs. publications 
 
 
Fig. 5: Fitted line plot of New Zealand schools’ patents vs. publications 
 
 Figs. 3-5 all display a positive, linear relationship between the volume of publications 
and patenting happening per HEI in all three countries. For Ireland (Fig. 4) and New Zealand 
(Fig. 5) there is a noticeable lag in the left tail, where the volume of publications is increasing 
and patenting is not. These data points represent the earliest years in this data set where 
publishing increased steadily but virtually no patenting was occurring. For New York and 
Ireland, the strong correlation between the data is reinforced by R2 values above 80%, at 82.5% 
and 88.4% respectively. The correlation is slightly weaker for the New Zealand data, as is 
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visualized by the right tail in Fig. 5 dipping slightly. The most likely explanation is that this is a 
hazard of small sample sizes – with data from only eight schools in that country, a single “down” 
year in patenting can quickly look like a grievous outlier. 
 
 
Fig. 6: Time series comparison 1973-2007 of patenting figures for Med vs. Non-Med HEIs in 
New York State, Ireland, and New Zealand, respectively (clockwise from top left) 
 
 Having separated the data within each country’s totals by whether or not each HEI had a 
medical school, we are able to see the jump in productivity appreciated by those with medical 
schools. The data is noisier in Ireland and New Zealand, but the overall trend matches that of the 
larger New York sample size where growth of Med patenting outstrips that of Non-Med 
patenting. In all three countries, patenting growth increases exponentially in the late 1980’s. 
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Fig. 7: Time series comparison 1973-2007 of publishing figures for Med vs. Non-Med HEIs in 
New York State, Ireland, and New Zealand, respectively (clockwise from top left) 
 
 The charts in Fig. 7 demonstrate that publishing volume per Med institution outpaced 
Non-Med institutions, similar to the patenting figures, but the discrepancy is significantly less 
severe. The gap in per HEI figures between Med and Non-Med might be attributable to school 
size (if HEIs with Med tend to be larger), but that data was not readily available to confirm this. 
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Fig. 8: Fitted line plot of Med publications vs. Med patents in New York State, Ireland, and New 
Zealand, respectively (clockwise from top left) 
 These graphs of Fig. 8, just for the Med HEIs in these countries, demonstrate the positive 
linear relationship between patenting and publishing observed earlier for the total country 
figures. The same lag is still apparent in Ireland and New Zealand – the left tail of those graphs 
illustrating increased publishing without acceleration of patent rates in the earliest years of this 
data set. Interestingly, though, the right tail of each graph shows slight deceleration in the 
publishing rate at Med HEIs in all three countries. 
 This indicates that the patenting process, and the secrecy required to maintain the 
patentability of an idea, may be affecting publishing. This would be a clear case of the “third 
mission” – the entrepreneurial university – interfering with research, the knowledge creation of 
the “second mission.” To compare these graphs with the same patenting vs. publishing figures 
for Non-Med schools in these countries, only New Zealand shows deceleration of publishing 
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rates. In New York State and Ireland, the right tail of the patent vs. publishing graphs for Non-
Med schools points upward, as one would expect with positively related, highly correlated data. 
 
Discussion 
 
 The above data suggests that the two premises of this study are likely correct: (1) that 
patenting at HEIs increased and accelerated dramatically per institution after the Bayh-Dole Act 
of 1980, accounting for lag time, and (2) that the pressure to patent biotechnology innovations 
may be causing faculty at HEIs with medical schools to pull back on publishing efforts in favor 
of patenting. 
 Further study of this subject should account for the changing sizes of these institutions in 
terms of faculty and students, and a rigorous assessment of outcomes. That is, the economic 
impact on individuals and institutions associated with particular patents. The outlier-type nature 
of commercial successes in biotechnology means every patent should not be weighted equally, 
and that could be accounted for with a more comprehensive data set for measuring levels of 
commercialization. 
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Appendix 
 
Fig. 9: Fitted line plot of Non-Med publications vs. Non-Med patents in New York State, 
Ireland, and New Zealand, respectively (clockwise from top left) 
 
